We previously demonstrated that a simultaneous overexpression of PARP-1 and CAF-1/p60 was a still more reliable prognosticator of poor outcome compared to CAF-1/p60 alone in oral carcinoma [51]. This evidence concerns the gene PARP1 and lip and oral cavity carcinoma.